Myria Biosciences
PrivateLast Round
Pre Seed
Jun 20, 2024
Company Overview
Myria Biosciences is a biotechnology company that develops therapeutic molecules using its synthetic intelligence platform to transform drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myria Biosciences Comparables
Compare Myria Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomia | 87% | |
| Generare | 84% | |
| Protuoso Biosciences | 82% | |
Myria Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jun 20, 2024 |
Myria Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital Blue Partners | Pre Seed |
| Rockmount Seed Investments | Pre Seed |
| The Creator Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Monthly visitors increased 46% MoM.
- Jul 2, 2025
Monthly visitors increased 553% MoM.
Myria Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Myria Biosciences's valuation, stock price, and market status.